Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Trial of the Safety, Pharmacokinetics, Biodistribution and Dosimetry of 68Ga-LNC1007 Injection in Adult Healthy Volunteers and Solid Tumor Patients

NCT06463782 is registered in ClinicalTrials.gov with Yantai LNC Biotechnology Singapore PTE. LTD. as lead sponsor.

NCT NCT06463782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06463782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Trial of the Safety, Pharmacokinetics, Biodistribution and Dosimetry of 68Ga-LNC1007 Injection in Adult Healthy Volunteers and Solid Tumor Patients
Lead sponsor
Yantai LNC Biotechnology Singapore PTE. LTD.
Phase
Phase 1
Overall status
Completed
Start date
January 2, 2025
Completion date
May 27, 2025
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer patients, healthy volunteers